Abrenica, Jayson .
HRN: 20-85-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/15/2022
07/21/2022
IVT
165mg
Q6
Pcap
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes